Exchange: NASDAQ·Updated 10:04 AM EDT
GRI logo

GRIGRI Bio Inc

$1.50
$0.00
(0.00%)
Today
Mkt Cap$2.66M
Vol4,068.00
News
all
press releases
GRI Bio Reports Positive Study Results For Chronic Lung Disease, But Stock Slumps 20% — What Happened?
The company said that the new data indicate that GRI-0621 may support the regeneration of lung tissue.
Stocktwits
GRI Bio Drug Shows Promising Lung Function Recovery In Patients With Thickened Lungs
GRI Bio shared promising data from a Phase 2a trial for idiopathic pulmonary fibrosis, a chronic lung disease with no known cause.read more...
Benzinga
Barclays lifts Kojamo, I-RES ratings; cuts Grainger on low yield
investing.com
<
...
1
>

Advertisement|Remove ads.